Risk Analysis
Welcome.
Sign in or register.
Refer A Friend
|
Contact Us
Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
Tracking 1053 U.S. listed China Stocks and Counting...
Tracking 1536 U.S. Stocks and Counting...
Home
Market Activity
Shell Activity
Research
Message Boards
GeoBlog
About
Recent Filings
Highs
Lows
Gainers
Losers
Volume Leaders
GeoAlerts
Corporate Actions
Business News
GEO Summary Alerts, August 17, 2010
Tuesday, August 17, 2010, 9:30 AM ET -
LGL
--"today announced results for the quarter ended June 30, 2010. Revenues Increase 73.2% from Second Quarter 2009, with Basic and Diluted EPS of $0.97. Total revenues for the three-month period ended June 30, 2010 were approximately $12,535,000, an increase of 73.2% from the comparable period in 2009. Net income for the three-month period ended June 30, 2010 wasapproximately $2,177,000, compared with a net loss of approximately ($937,000) for the comparable period in 2009. Basic and diluted earnings pershare was $0.97 for the three-month period ended June 30, 2010, compared to loss per share of ($0.43) for the comparable period in 2009."
see release
CNRD
-- "For the quarter ended June 30, 2010, Conrad achieved net income of $3.6 million and earnings per diluted share of $0.56 compared to net income of $1.6 million and earnings per diluted share of $0.26 during the second quarter of 2009. The Company had net income of $5.4 million and earnings per diluted share of $0.83 for the six months ended June 30, 2010 compared to net income of $7.3 million and earnings per diluted share of $1.13 for the six months ended June 30, 2009. The diluted shares for the quarters and six months ended June 30, 2010 and June 30, 2009 are 6.5 million. The Company's financial reports are available at www.pinksheets.com."
see release
BSPM
-- "Revenue for the second quarter of 2010 increased 46.4% to approximately $19.4 million compared to $13.2 million for the second quarter of 2009. Sales of Xin Aoxing Capsules, Biostar's flagship product, increased by 41.7% to $12.7 million with a gross margin of 85.0%, compared to $8.9 million in the second quarter of 2009. During the second quarter of 2010, sales of Xin Aoxing represented 65.4% of total revenues and benefited from $1.7 million in sales from the Beijing, Tianjing and Shanghai markets which were launched in the first quarter of 2010, in addition to $1.6 million from four new provincial markets including Jiangsu, Jiangxi, Chongqing and Hebei province."
see release
Disclaimer
You acknowledge that GeoInvesting is not registered as an exchange, broker-dealer or investment adviser under any federal or state securities laws, and that GeoInvesting has not provided you with any individualized investment advice or information. Nothing in the website should be construed to be an offer or sale of any security. You should consult your financial adviser before making any investment decision or engaging in any securities transaction as investing in any securities mentioned in the website may or may not be suitable to you or for your particular circumstances.
Investor Relations
Do you represent a publically traded Asian or U.S. company? Let the GeoTeam help you communicate with investors.
Sign up now!